NasdaqCM - Delayed Quote USD
Nexalin Technology, Inc. (NXL)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 7:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-3,714.8280
-3,835.3840
-2,215.6990
-1,076.7910
-863.4740
Investing Cash Flow
4,331.9030
4,452.8720
-6,794.8790
--
-0.6480
Financing Cash Flow
--
-200.0000
8,511.5430
1,660.1330
879.1310
End Cash Position
848.7960
580.2300
162.7430
661.7780
78.4360
Capital Expenditure
-174.8240
-109.2790
--
--
-0.6480
Issuance of Capital Stock
--
--
8,545.2700
1,433.7670
884.0820
Issuance of Debt
--
--
--
200.0000
22.9160
Repayment of Debt
--
-200.0000
-37.2000
-9.6000
-89.6170
Free Cash Flow
-3,889.6520
-3,944.6630
-2,215.6990
-1,076.7910
-864.1220
12/31/2020 - 9/16/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSGM BioSig Technologies, Inc.
0.8690
0.00%
VTAK Catheter Precision, Inc.
0.6201
-29.17%
TNON Tenon Medical, Inc.
3.6200
-1.09%
DXCM DexCom, Inc.
73.44
-1.88%
IRTC iRhythm Technologies, Inc.
75.68
-3.12%
NUWE Nuwellis, Inc.
1.8600
+13.41%
TRIB Trinity Biotech plc
1.9300
+5.46%
BBLG Bone Biologics Corporation
1.7300
+0.58%
BJDX Bluejay Diagnostics, Inc.
0.1053
+5.83%
TMDX TransMedics Group, Inc.
125.17
+2.60%